Related references
Note: Only part of the references are listed.Validation of the ACR-EULAR criteria for primary Sjogren's syndrome in a Dutch prospective diagnostic cohort
Jolien F. van Nimwegen et al.
RHEUMATOLOGY (2018)
Degradation of proteoglycan 4/lubricin by cathepsin S: Potential mechanism for diminished ocular surface lubrication in Sjogren's syndrome
Suresh C. Regmi et al.
EXPERIMENTAL EYE RESEARCH (2017)
Pharmacodynamic Monitoring of Ro5459072, a small Molecule Inhibitor of Cathepsin s
Michel Theron et al.
FRONTIERS IN IMMUNOLOGY (2017)
Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjogren's Syndrome
Mihir Shah et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
Early diagnosis of primary Sjogren's syndrome: EULAR-SS task force clinical recommendations
Pilar Brito-Zeron et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)
Cathepsin S-Dependent Protease-Activated Receptor-2 Activation: A New Mechanism of Endothelial Dysfunction
David J. Nikolic-Paterson
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjogren's Syndrome
Zhen Meng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2016)
Making the diagnosis of Sjogren's syndrome in patients with dry eye
Kenneth A. Beckman et al.
CLINICAL OPHTHALMOLOGY (2016)
Lactoferrin-Loaded Contact Lenses: Eye Protection Against Oxidative Stress
Valentina Pastori et al.
CORNEA (2015)
Cystatin C is a disease-associated protein subject to multiple regulation
Yuekang Xu et al.
IMMUNOLOGY AND CELL BIOLOGY (2015)
Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming
Khader Valli Rupanagudi et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Cysteine cathepsins and extracellular matrix degradation
Marko Fonovic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects
Christopher D. Payne et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Advances in the understanding and treatment of systemic complications in Sjogren's syndrome
Pilar Brito-Zeron et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
Cathepsin S Causes Inflammatory Pain via Biased Agonism of PAR2 and TRPV4
Peishen Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Cathepsin S Signals via PAR2 and Generates a Novel Tethered Ligand Receptor Agonist
Sarina B. Elmariah et al.
PLOS ONE (2014)
Tear Cathepsin S as a Candidate Biomarker for Sjogren's Syndrome
Sarah F. Hamm-Alvarez et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Practical issues concerning tear protein assays in dry eye
Sharon D'Souza et al.
EYE AND VISION (2014)
A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjogren's syndrome
Mihir Shah et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Post-collection processing of Schirmer strip-collected human tear fluid impacts protein content
Aleksandra K. Denisin et al.
ANALYST (2012)
Determination of cathepsin S abundance and activity in human plasma and implications for clinical investigation
Jennifer M. Cox et al.
ANALYTICAL BIOCHEMISTRY (2012)
Overexpression of Cathepsin S Induces Chronic Atopic Dermatitis in Mice
Nari Kim et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Accumulation of Secretory Vesicles in the Lacrimal Gland Epithelia Is Related to Non-Sjogren's Type Dry Eye in Visual Display Terminal Users
Mizuka Kamoi et al.
PLOS ONE (2012)
Changes in Rab3D Expression and Distribution in the Acini of Sjogren's Syndrome Patients Are Associated With Loss of Cell Polarity and Secretory Dysfunction
Veronica Bahamondes et al.
ARTHRITIS AND RHEUMATISM (2011)
Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity
Mark Baugh et al.
JOURNAL OF AUTOIMMUNITY (2011)
Cathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosis
Dana Haves-Zburof et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer
Eva Kolwijck et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjogren's syndrome-like exocrinopathy
Katja Schenke-Layland et al.
EXPERIMENTAL EYE RESEARCH (2010)
Increased Expression of Cathepsins and Obesity-Induced Proinflammatory Cytokines in Lacrimal Glands of Male NOD Mouse
Xiaodong Li et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Role of lactoferrin in the tear film
J. L. Flanagan et al.
BIOCHIMIE (2009)
Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland
Kaijin Wu et al.
EXPERIMENTAL EYE RESEARCH (2009)
Cathepsin S Regulates Class II MHC Processing in Human CD4+ HLA-DR+ T Cells
Cristina Maria Costantino et al.
JOURNAL OF IMMUNOLOGY (2009)
Local production of secretory IgA in the eye-associated lymphoid tissue (EALT) of the normal human ocular surface
Erich Knop et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens:: Disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis
Richard A. Dean et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Autoimmune dacryoadenitis of NOD/LtJ mice and its subsequent effects on tear protein composition
Maire E. Doyle et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis
MP Rogan et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients
N Cimerman et al.
CLINICA CHIMICA ACTA (2000)
Share Paper
